Clinical Trial Update: Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for SHR-1314 in moderate-to-severe plaque psoriasis, across Phase 1 and Phase 2, and the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• SHR-1314 (SHR-1314)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Moderate-to-severe Chronic Plaque Psoriasis | Phase 1, Phase 2 | Status: COMPLETED